Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2013 - 2026)

Agios Pharmaceuticals has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.05 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 131.25% year-over-year to 0.05; the trailing twelve-month figure through Mar 2026 stood at 0.05 (up 131.25% YoY), and the FY2025 full-year result was 0.04, up 30.02% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.05, up from 0.04 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.05 in Q1 2026, with the low at 0.0 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.02 across 5 years, with a median of 0.02 in 2025.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio slumped 99.14% — and 2023, when it soared 2552.53%.
• Agios Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2022, then soared by 134.35% to 0.03 in 2023, then slipped by 23.42% to 0.02 in 2024, then surged by 90.63% to 0.04 in 2025, then surged by 32.13% to 0.05 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.05 (Q1 2026), 0.04 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.